Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NBEAL2 |
| Upstream (Parents) |
|---|
| (<<) BMP4 → NBEAL2 |
| (<<) C1orf116 → NBEAL2 |
| (<<) AP1M2 → NBEAL2 |
| (<<) TRAF5 → NBEAL2 |
| (<<) HBEGF → NBEAL2 |
| (<<) ZBED4 → NBEAL2 |
| (<<) CIZ1 → NBEAL2 |
| Downstream (Children) |
|---|
| NBEAL2 → WLS (>>) |
| NBEAL2 → ZNF551 (>>) |
| NBEAL2 → BMP4 (>>) |
| NBEAL2 → SH3TC2 (>>) |
| NBEAL2 → FGF22 (>>) |
| NBEAL2 → DPY19L1P1 (>>) |
| NBEAL2 → OMG (>>) |
| NBEAL2 → NOL12 (>>) |
| NBEAL2 → TAPBP (>>) |
| NBEAL2 → TMEM132A (>>) |
| NBEAL2 → TTC18 (>>) |
| NBEAL2 → PRRG2 (>>) |
| NBEAL2 → MAPKBP1 (>>) |
| NBEAL2 → CIZ1 (>>) |
| NBEAL2 → DNPEP (>>) |
| NBEAL2 → WFS1 (>>) |
| NBEAL2 → SEPT8 (>>) |
| NBEAL2 → NACA2///NACAP1///NACA (>>) |
| NBEAL2 → UAP1L1 (>>) |
